Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy;
Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1051-1056. doi: 10.47162/RJME.61.4.07.
Healthy adipose tissue contains a wide variety of innate and adaptive immune cells, including macrophages, dendritic cells, mast cells, eosinophils, neutrophils, and lymphocytes. Numerous signaling molecules in the adipose microenvironment can positively or negatively modulate angiogenic processes, regulate the interaction between the vascular system and adipocytes, and participate in tumor progression. Mast cells are involved in the new formation or metabolism of fat, are present in abundant quantities in fatty tissue, among fat cells, and a number of mediators released from mast cells play a role in adipogenesis. Moreover, mast cells produce several pro-angiogenic factors and are involved in tumor angiogenesis. In this context, the angiogenic effect might be amplified when the adipocytes and mast cells act in concert, and treatment of adipose tissue- and mast cell-associated cancers with anti-angiogenic drugs may represent an alternative or adjuvant strategy for the treatment of these tumors.
健康的脂肪组织中含有多种先天和适应性免疫细胞,包括巨噬细胞、树突状细胞、肥大细胞、嗜酸性粒细胞、中性粒细胞和淋巴细胞。脂肪微环境中的许多信号分子可以正向或负向调节血管生成过程,调节血管系统与脂肪细胞之间的相互作用,并参与肿瘤进展。肥大细胞参与脂肪的新形成或代谢,在脂肪组织中、脂肪细胞之间大量存在,肥大细胞释放的许多介质在脂肪生成中发挥作用。此外,肥大细胞产生多种促血管生成因子,并参与肿瘤血管生成。在这种情况下,当脂肪细胞和肥大细胞协同作用时,血管生成效应可能会放大,并且用抗血管生成药物治疗脂肪组织和肥大细胞相关的癌症可能是治疗这些肿瘤的替代或辅助策略。